- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Total 1140 results
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityActive, not recruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer AJCC v7United States
-
Dana-Farber Cancer InstitutePfizer; Astellas Pharma IncCompletedCastration-resistant Prostate CancerUnited States
-
DendreonTerminatedCastration-Resistant Prostate CancerUnited States
-
The Netherlands Cancer InstituteBayerCompletedBone Metastases | Prostate Cancer MetastaticNetherlands
-
AstraZenecaScandinavian Prostate Cancer GroupCompletedNon-Metastatic Prostate CancerSweden, Finland, Norway, Denmark
-
AstraZenecaCompletedNon-Metastatic Prostate CancerFinland
-
Emmanuel Antonarakis, MDMillennium Pharmaceuticals, Inc.WithdrawnProstate Cancer | Castration-resistant Prostate CancerUnited States
-
National Cancer Institute (NCI)Enrolling by invitationProstatic Neoplasms | Prostate Cancer | Metastatic Prostate Cancer | Prostate Neoplasms | Prostatic CancerUnited States
-
Celsee DiagnosticsWithdrawnMetastatic Prostate Cancer, CTC
-
AstraZenecaCompletedNon-metastatic Prostate CancerUnited States, Canada
-
AstraZenecaCompletedNon-Metastatic Prostate CancerCzech Republic, Italy, South Africa, United Kingdom, Germany, Poland, Netherlands, Austria, Belgium, Hungary, Israel, Portugal, Mexico, Spain, Australia, Ireland
-
Hellenic Cooperative Oncology GroupSanofiCompletedBone Metastatic Prostate CancerGreece
-
BayerCompleted
-
British Columbia Cancer AgencyAchieve Life SciencesCompletedCastration Resistant Prostate CancerCanada, United States
-
Stanford UniversityNational Cancer Institute (NCI)CompletedMultiple Myeloma | Recurrent Prostate Cancer | Plasmacytoma | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
National Cancer Institute (NCI)RecruitingProstatic Neoplasms | Prostate Cancer | Metastatic Prostate Cancer | Cancer Of Prostate | ProstateUnited States
-
Progenics Pharmaceuticals, Inc.CompletedStudy of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer (CONDOR)Prostate Cancer | Prostate Adenocarcinoma | Prostate Cancer Recurrent | Prostate Cancer MetastaticUnited States, Canada
-
National Cancer Institute (NCI)Enrolling by invitationProstate Cancer | Metastatic Prostate Cancer | Cancer Of Prostate | Prostate Neoplasms | Prostatic CancerUnited States
-
ExelixisTerminatedPain | Prostatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerUnited States, Canada, Australia, United Kingdom, Ireland
-
University Hospital, GhentRecruitingProstate Cancer | Metastatic Cancer | Prostate Cancer Recurrent | Prostate Cancer Metastatic | OligometastasisBelgium
-
ExelixisCompletedPain | Prostatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerBelgium, France, Italy, Canada, United States, Germany, United Kingdom, Australia, Netherlands, Spain, Austria, Ireland, Puerto Rico, Sweden
-
Chang Gung Memorial HospitalRecruiting
-
Novartis PharmaceuticalsCompletedMetastatic Hormone Refractory Prostate CancerUnited States, France, Spain, Belgium, Singapore, Italy, Australia, Germany
-
Paul Mathew, MDHoosier Cancer Research Network; Tesaro, Inc.TerminatedMetastatic Prostate CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Oregon Health and Science UniversityCompletedProstate Cancer | Metastatic, Androgen Independent Prostate CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedProstate Cancer | Metastatic CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Astellas Pharma US, Inc.; Medivation, Inc.; Biologics...Active, not recruitingRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States, Canada, Puerto Rico
-
Duke UniversityExelixisTerminatedProstate Cancer | Prostate Cancer Adenocarcinoma | Non-MetastaticUnited States
-
SanofiTerminated
-
Nerviano Medical SciencesCompletedMetastatic Hormone Refractory Prostate CancerItaly
-
UNICANCERBayerRecruitingProstate Cancer MetastaticSpain, France, Ireland, Belgium
-
Azienda Ospedaliero-Universitaria CareggiCompletedMetastatic Prostate Cancer | Elderly PatientsItaly
-
SanofiCompletedProstate Cancer MetastaticUnited Kingdom, Austria, Belgium, Czechia, France, Germany, Greece, Iceland, Ireland, Italy, Netherlands, Norway, Spain
-
Duke UniversityUnited States Department of DefenseCompletedMetastatic Hormone Refractory Prostate CancerUnited States
-
Karyopharm Therapeutics IncActive, not recruitingAcute Myeloid Leukemia (AML) | Metastatic Colorectal Cancer (mCRC) | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Relapsed/Refractory Multiple Myeloma (RRMM) | Higher-Risk Myelodysplastic Syndrome (HR-MDS) | Newly Diagnosed Intermediate/High-Risk MDSUnited States, France, Canada, Spain, China
-
Asan Medical CenterUnknownCastration-resistant Prostate CancerKorea, Republic of
-
CHU de Quebec-Universite LavalCanadian Institutes of Health Research (CIHR)Not yet recruitingCancer | Prostate Cancer | Metastatic Cancer | Metastatic Prostate Cancer
-
Institut du Cancer de Montpellier - Val d'AurelleCompletedProstate Cancer | Bone Metastases | Hormone-resistant Prostate CancerFrance
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedProstate Cancer | Metastatic CancerUnited States
-
IpsenActive, not recruitingMetastatic Prostate Cancer | Advanced Prostate Cancer | Locally Advanced Prostate CancerChina
-
Fondazione del Piemonte per l'OncologiaNational Cancer Institute (NCI); University of Pisa; Royal Marsden NHS Foundation... and other collaboratorsRecruitingProstate Cancer | Prostate Cancer Recurrent | Prostate Cancer Metastatic | Prostate Cancer AggressivenessItaly
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.Active, not recruitingProstate Cancer | Cancer of the Prostate | Nonmetastatic Castration-Resistant Prostate CancerHong Kong, Canada, China, Germany, Spain, Netherlands, United Kingdom, Korea, Republic of, Taiwan, Australia, Denmark, France, United States, Singapore, Poland, Malaysia, Turkey, Belgium, Argentina, Thailand, Slovakia, Brazil, Finland, Ita... and more
-
MacroGenicsRecruitingProstate Cancer Recurrent | Immunotherapy | Androgen-Independent Prostatic Cancer | Androgen-Resistant Prostatic Cancer | Hormone Refractory Prostatic Cancer | Immune Checkpoint Inhibitor | Androgen-Independent Prostatic Neoplasms | Androgen-Insensitive Prostatic Cance | Inhibitory Checkpoint MoleculeUnited States, Spain, France, Belgium, United Kingdom, Poland, Georgia, Bulgaria, Puerto Rico, Australia
-
Movember FoundationKing's College London; Centre hospitalier de l'Université de Montréal (CHUM); University of California, San Francisco and other collaboratorsActive, not recruitingINTense ExeRcise for surviVAL Among Men With Metastatic Prostate Cancer (INTERVAL - GAP4) (INTERVAL)Metastatic Prostate CancerUnited States, Australia, Netherlands, Canada, United Kingdom, Germany, Ireland
-
Calibr, a division of Scripps ResearchTerminatedMetastatic Castration-Resistant Prostate AdenocarcinomaUnited States
-
Ignacio Puche SanzChinese University of Hong Kong; UMC Utrecht; University of Padova; Medical University... and other collaboratorsNot yet recruitingProstate Cancer MetastaticSpain
-
Sun Yat-sen UniversityNot yet recruiting
-
Medical University of ViennaRecruitingLocally Advanced and Metastatic Prostate CancerAustria
-
Duke UniversityCompleted
-
University of NebraskaNational Cancer Institute (NCI)TerminatedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the ProstateUnited States